NM_000218.3:c.*479G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000218.3(KCNQ1):​c.*479G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 457,636 control chromosomes in the GnomAD database, including 3,395 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 945 hom., cov: 34)
Exomes 𝑓: 0.11 ( 2450 hom. )

Consequence

KCNQ1
NM_000218.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0380

Publications

14 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1-AS1 (HGNC:42790): (KCNQ1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-2848482-G-A is Benign according to our data. Variant chr11-2848482-G-A is described in ClinVar as Benign. ClinVar VariationId is 304249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.*479G>A 3_prime_UTR_variant Exon 16 of 16 ENST00000155840.12 NP_000209.2 P51787-1Q96AI9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.*479G>A 3_prime_UTR_variant Exon 16 of 16 1 NM_000218.3 ENSP00000155840.2 P51787-1

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15675
AN:
152098
Hom.:
944
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0973
Gnomad AMI
AF:
0.153
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.0995
Gnomad EAS
AF:
0.0596
Gnomad SAS
AF:
0.0861
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.0925
Gnomad OTH
AF:
0.107
GnomAD2 exomes
AF:
0.125
AC:
16412
AN:
131708
AF XY:
0.117
show subpopulations
Gnomad AFR exome
AF:
0.100
Gnomad AMR exome
AF:
0.263
Gnomad ASJ exome
AF:
0.0927
Gnomad EAS exome
AF:
0.0659
Gnomad FIN exome
AF:
0.124
Gnomad NFE exome
AF:
0.0929
Gnomad OTH exome
AF:
0.111
GnomAD4 exome
AF:
0.109
AC:
33366
AN:
305420
Hom.:
2450
Cov.:
0
AF XY:
0.105
AC XY:
18242
AN XY:
173828
show subpopulations
African (AFR)
AF:
0.101
AC:
881
AN:
8692
American (AMR)
AF:
0.263
AC:
7200
AN:
27342
Ashkenazi Jewish (ASJ)
AF:
0.0946
AC:
1036
AN:
10954
East Asian (EAS)
AF:
0.0642
AC:
600
AN:
9352
South Asian (SAS)
AF:
0.0930
AC:
5546
AN:
59658
European-Finnish (FIN)
AF:
0.121
AC:
1534
AN:
12640
Middle Eastern (MID)
AF:
0.0938
AC:
109
AN:
1162
European-Non Finnish (NFE)
AF:
0.0934
AC:
15068
AN:
161294
Other (OTH)
AF:
0.0972
AC:
1392
AN:
14326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1949
3898
5848
7797
9746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15694
AN:
152216
Hom.:
945
Cov.:
34
AF XY:
0.105
AC XY:
7826
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0974
AC:
4044
AN:
41528
American (AMR)
AF:
0.170
AC:
2606
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0995
AC:
345
AN:
3468
East Asian (EAS)
AF:
0.0596
AC:
309
AN:
5186
South Asian (SAS)
AF:
0.0860
AC:
415
AN:
4828
European-Finnish (FIN)
AF:
0.121
AC:
1285
AN:
10604
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.0925
AC:
6290
AN:
67978
Other (OTH)
AF:
0.105
AC:
223
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
711
1423
2134
2846
3557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0698
Hom.:
118
Bravo
AF:
0.108
Asia WGS
AF:
0.0690
AC:
241
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27531917, 22199116) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Long QT syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Atrial fibrillation, familial, 3 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jervell and Lange-Nielsen syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Short QT syndrome type 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Congenital long QT syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.4
DANN
Benign
0.42
PhyloP100
0.038
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2519184; hg19: chr11-2869712; API